We used ChIP to investigate the extent of H3Ac and H3K4me3 marking associated with the PRKCB promoter in CLL and normal B cells, focussing on the region of DNA containing the SP1 binding sites (Fig. 4a and b). The gene discussed is SP1; the disease is B-cell chronic lymphocytic leukemia.